Merit Medical Systems, Inc. (NASDAQ:MMSI) Director F. Ann Millner Sells 3,780 Shares

Merit Medical Systems, Inc. (NASDAQ:MMSI) Director F. Ann Millner sold 3,780 shares of the business’s stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $36.67, for a total value of $138,612.60. Following the completion of the transaction, the director now owns 13,298 shares in the company, valued at approximately $487,637.66. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

MMSI stock traded down $1.11 during trading on Monday, hitting $35.07. The company had a trading volume of 797,200 shares, compared to its average volume of 456,322. The firm has a market cap of $2.03 billion, a PE ratio of 20.75, a price-to-earnings-growth ratio of 1.74 and a beta of 1.03. Merit Medical Systems, Inc. has a 1-year low of $35.00 and a 1-year high of $66.34. The firm has a 50-day moving average price of $47.65 and a 200-day moving average price of $55.25. The company has a quick ratio of 1.27, a current ratio of 2.42 and a debt-to-equity ratio of 0.48.

Merit Medical Systems (NASDAQ:MMSI) last released its earnings results on Thursday, July 25th. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.50 by ($0.08). Merit Medical Systems had a return on equity of 10.40% and a net margin of 4.10%. The business had revenue of $255.50 million for the quarter, compared to analyst estimates of $258.58 million. During the same quarter in the previous year, the firm posted $0.43 EPS. The business’s revenue for the quarter was up 13.7% on a year-over-year basis. Sell-side analysts anticipate that Merit Medical Systems, Inc. will post 1.79 earnings per share for the current year.

Several equities analysts recently issued reports on the company. ValuEngine cut Merit Medical Systems from a “hold” rating to a “sell” rating in a research report on Saturday, August 10th. Needham & Company LLC cut Merit Medical Systems from a “buy” rating to a “hold” rating in a research report on Friday, July 26th. Sidoti set a $74.00 price target on Merit Medical Systems and gave the company a “buy” rating in a research report on Friday, July 26th. BidaskClub cut Merit Medical Systems from a “sell” rating to a “strong sell” rating in a research report on Tuesday, July 23rd. Finally, Barrington Research restated a “buy” rating and issued a $59.00 price target on shares of Merit Medical Systems in a research report on Friday, July 26th. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $61.75.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Capital Investment Advisory Services LLC acquired a new position in Merit Medical Systems during the 2nd quarter worth approximately $29,000. Meeder Asset Management Inc. acquired a new position in Merit Medical Systems during the 2nd quarter worth approximately $32,000. Financial Gravity Wealth Inc. increased its position in Merit Medical Systems by 5,241.7% during the 2nd quarter. Financial Gravity Wealth Inc. now owns 641 shares of the medical instruments supplier’s stock worth $38,000 after purchasing an additional 629 shares during the period. Manchester Capital Management LLC acquired a new stake in shares of Merit Medical Systems in the 1st quarter worth approximately $55,000. Finally, BB&T Corp acquired a new stake in shares of Merit Medical Systems in the 2nd quarter worth approximately $204,000. Institutional investors own 97.19% of the company’s stock.

About Merit Medical Systems

Merit Medical Systems, Inc manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. The company operates through Cardiovascular and Endoscopy segments. It provides peripheral intervention products, including access, angiography, intervention, and drainage and biopsy for diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, and electrophysiology and cardiac rhythm management products to treat various heart conditions.

Featured Story: What are retained earnings?

Insider Buying and Selling by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.